Clinical trial
Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary…
NCT00297661 · University of Bern, Other · Completed
Key facts
| NCT number | NCT00297661 |
|---|---|
| Title | Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization |
| Official title | Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization: SIRTAX Trial |
| Lead sponsor | University of Bern, Other |
| Collaborators | University of Zurich |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Heart Disease |
| Intervention type | Device |
| Interventions | Sirolimus-eluting stent, Paclitaxel-eluting stent |
| Enrollment | 1,012 |
| Start date | Apr 1, 2003 |
| First posted | Feb 28, 2006 |
| Last update posted | Oct 20, 2006 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: